| For: | Vlachakis PK, Theofilis P, Tousoulis D. SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat. World J Cardiol 2024; 16(11): 669-672 [PMID: 39600990 DOI: 10.4330/wjc.v16.i11.669] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v16/i11/669.htm |
| Number | Citing Articles |
| 1 |
Zuyuan Huang, Guoxing Ling, Chen Fang, Zimin Wu, Shigao Ye, Chuanliang Zhang, Cheng Luo, Baoshi Zheng. Mechanisms and Therapeutic Potential of Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure. Reviews in Cardiovascular Medicine 2026; 27(4) doi: 10.31083/RCM45833
|
| 2 |
Akash De, Arnab Sarkar, Tanmoy Banerjee, Rudranil Bhowmik, Shuvam Sar, Md. Adil Shaharyar, Sanmoy Karmakar, Nilanjan Ghosh. MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1613844
|